Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of the Virtual Ophthalmology Clinic on medical students' learning: a randomised controlled trial.

Eye (London, England)·2013
Same author

Specific unwillingness to donate eyes: the impact of disfigurement, knowledge and procurement on corneal donation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Secondary glaucoma after paediatric cataract surgery.

The British journal of ophthalmology·2007
Same author

Consent for corneal donation: the effect of age of the deceased, registered intent and which family member is asked about donation.

The British journal of ophthalmology·2006
Same author

Congenital iris ectropion as an indicator of variant aniridia.

The British journal of ophthalmology·2006
Same author

Multifocal VEP in children: its maturation and clinical application.

The British journal of ophthalmology·2004

Related Experiment Video

Updated: Jul 13, 2026

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Molteno implant surgery for advanced glaucoma

R Thomas1, S C Gieser, F Billson

  • 1Department of Ophthalmology, Christian Medical College, Vellore, Tamil Nadu.

Australian and New Zealand Journal of Ophthalmology
|February 1, 1995
PubMed
Summary

Molteno implants are a last resort for glaucoma filtration surgery. While improved surgical techniques reduce complications, their success may be enhanced by antimitotics, warranting further investigation.

More Related Videos

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Related Experiment Videos

Last Updated: Jul 13, 2026

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery

Background:

  • Conventional filtering surgery with adjunctive antimitotics may reduce the need for Molteno implants in advanced glaucoma.
  • Molteno implants are a surgical option for glaucoma with a poor prognosis.

Purpose of the Study:

  • To review the current status, results, and complications of Molteno implants in glaucoma management.
  • To evaluate the role of antimitotics in conjunction with Molteno implants.

Main Methods:

  • Literature review.
  • Analysis of practical experience from two university ophthalmology departments.

Main Results:

  • Improvements in Molteno implant design and surgical techniques have reduced overfiltration.
  • Complications associated with Molteno implants persist, although their incidence may be decreasing.
  • Antimitotics may potentially increase the success rates of Molteno implants.

Conclusions:

  • Molteno implants remain a viable option for refractory glaucoma when conventional filtration fails.
  • They are considered a last resort for glaucoma filtration surgery.
  • The efficacy of antimitotics in improving Molteno implant success requires further research.